TG Therapeutics' Q1 2025 earnings report showed strong revenue growth, with Briumvi net revenues rising to $119.7m, prompting an increase in full-year revenue guidance. Despite a >15% drop in stock ...
Hosted on MSN
TG Metals Faces Shareholder Challenge Ahead of AGM
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An update from TG Metals Ltd. ( (AU:TG6)) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results